Suspension of trading
Oncternal Therapeutics, Inc. Stock
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:00:00 03/12/2024 +04
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/07/25 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/07/25 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 1.56M 1.37M 1.3M 1.18M 2.21M 150M 2.22M 15.49M 5.98M 76.34M 5.85M 5.72M 245M | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -32.38M -28.47M -26.93M -24.43M -45.89M -3.11B -46.14M -322M -124M -1.59B -122M -119M -5.1B | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 89.8 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 01/12/2017 |
Xin Nakanishi
BRD | Director/Board Member | 64 | 01/11/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -91.51% | 1.56M | |
| +2.64% | +7.07% | +11.87% | +38.40% | 47.97B | |
| +0.22% | +1.71% | +50.91% | +34.00% | 44.5B | |
| -1.58% | +5.65% | +359.34% | +598.06% | 43.93B | |
| +1.70% | +4.61% | +12.56% | +90.97% | 41.03B | |
| +0.51% | -0.61% | +5.18% | +46.87% | 29.85B | |
| -0.48% | +0.59% | +23.98% | +148.36% | 17.27B | |
| +0.08% | +9.30% | +8.41% | - | 15.34B | |
| +1.76% | +2.98% | +29.13% | +45.78% | 15.3B | |
| +1.97% | -2.82% | - | - | 14.82B | |
| Average | -1.79% | -0.37% | +55.71% | +113.87% | 27B | |
| Weighted average by Cap. | +0.71% | +2.97% | +79.47% | +158.52% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.49M 1.31M 1.24M 1.12M 2.11M 143M 2.12M 14.81M 5.72M 72.99M 5.59M 5.47M 235M | 785K 690K 653K 592K 1.11M 75.34M 1.12M 7.8M 3.01M 38.45M 2.95M 2.88M 124M |
| Net income | -44.17M -38.84M -36.74M -33.33M -62.61M -4.24B -62.94M -439M -170M -2.16B -166M -162M -6.95B | -39.48M -34.72M -32.84M -29.79M -55.96M -3.79B -56.26M -392M -152M -1.93B -148M -145M -6.21B |
| Net Debt | -63.64M -55.96M -52.93M -48.01M -90.2M -6.11B -90.68M -632M -244M -3.12B -239M -234M -10.02B | -33.94M -29.84M -28.23M -25.6M -48.1M -3.26B -48.36M -337M -130M -1.66B -127M -125M -5.34B |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
